Daiichi Sankyo — Drug Prices & Medicare Spending
Daiichi Sankyo manufactures 3 drugs tracked by Medicare Part D with total spending of $591.0M.
3
Drugs Tracked
$591.0M
Medicare Spending
$128.93
Avg Cost/Claim
100%
Have Generics
Daiichi Sankyo Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Savaysa | Edoxaban | $278.00 | Yes |
| 2 | Benicar | Olmesartan | $50.00 | Yes |
| 3 | Welchol | Colesevelam | $142.00 | Yes |
Frequently Asked Questions
Daiichi Sankyo manufactures 3 drugs tracked by Medicare Part D, with total annual spending of $591.0M.
Savaysa (Edoxaban) is the most expensive at $278.00 per claim.
3 of 3 Daiichi Sankyo drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.